Injective: Deflationary token burns support targets of $50 and $90. Aerodrome: Base’s leading DEX targets $3.50, with upside to $6-$8. Hyperliquid: Strong revenue drives $200-$300 targets des
Many crypto investors focus on projects that combine strong utility with growth potential. While large-cap assets often attract the most attention, several altcoins still offer room for significant gains if adoption continues to rise. Injective, Aerodrome, and Hyperliquid stand out for different reasons. Each project generates real network activity and revenue, while analysts see paths toward much higher valuations. Here is a closer look at three altcoins with ambitious targets and the fundamentals behind them.
Source: Trading View
Injective trades near $7.50 and remains focused on on-chain financial markets. The network supports products such as perpetual contracts and tokenized assets, giving traders access to advanced decentralized finance tools. A major attraction comes from a revenue-driven token burn model. Every month, the network repurchases and permanently removes INJ tokens from circulation. More than 7 million INJ have already been burned, creating a deflationary dynamic that many investors find appealing. Analysts believe a move to $50 would place INJ near a previous peak of $52.62. A more aggressive target of $90 would push valuation close to $10 billion. Reaching that level would require stronger adoption and higher activity across the ecosystem.
Source: Trading View
Aerodrome has become the leading exchange on the Base network and currently trades around $0.80. The platform uses a governance model that rewards long-term participation. Users who lock tokens gain voting power over liquidity incentives and receive a share of exchange revenue. Strong usage supports the bullish outlook. By April 2026, Aerodrome generated $185 billion in trading volume and $270 million in swap fees. Those figures highlight growing demand for services across the platform. A price target of $3.50 would place valuation at roughly $9.1 billion. Some analysts also see a path toward the $6 to $8 range if growth continues.
Source: Trading View
Hyperliquid trades around $89 to $90 and sits close to a recent high near $97. Among the projects discussed here, Hyperliquid already operates at the largest scale. Over the past year, revenue reached approximately $685 million. The platform also uses part of fee income to repurchase and burn HYPE tokens. Strong business performance has fueled optimism around future growth. Still, price targets of $200 and $300 come with major challenges. Those levels imply market capitalizations between $200 billion and $300 billion. Analysts estimate annual revenue would need to reach roughly $5 billion to justify such valuations.
Injective offers a mix of utility and consistent token burns. Aerodrome benefits from strong exchange activity and revenue sharing. Hyperliquid leads in scale but faces the highest valuation hurdle. Together, these three altcoins present intriguing opportunities for investors willing to balance risk with long-term upside potential.
